New Report Covers Interventional Neurology - Medical Devices Pipeline Assessment, 2017

Interventional Neurology - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Interventional Neurology currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interventional Neurology pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Interventional Neurology - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Interventional Neurology under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Interventional Neurology and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Interventional Neurology under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Alcyone Lifesciences Inc Amnis Therapeutics Ltd Anaconda BioMed SL Aneuclose LLC Apeliotus Technologies Arterain Medical Inc Avantec Vascular Corporation BioCure, Inc. Ceretrieve Ltd Codman & Shurtleff Inc Collagen Matrix Inc Cordis Corp CranioVation CVTec Cerebrovascular Technologies GmbH Dartmouth College DePuy Synthes Inc EchoGuide Medical, Inc. Ecole Polytechnique Federale de Lausanne Gaudi Vascular, Inc. Hansen Medical Inc Hansjorg Wyss Institute for Biologically Inspired Engineering Hibernia Medical Insera Therapeutics, LLC InspireMD Inc Medikit Co Ltd Medtronic plc Merlin MD Pte. Ltd. Metactive Medical LLC MicroPort Scientific Corp MicroVention, Inc. MindFrame Inc MiVi Neuroscience, LLC MRI Interventions Inc NEOS Surgery SL Neuravi Ltd NeuroInterventional Therapeutics, Inc. NeuroInterventions Neurosigma Inc Neurosyntec LLC. NexGen Medical Systems Inc NSVascular, Inc. Oxford Endovascular Limited Palmaz Scientific Inc Penumbra Inc Philips Healthcare PhotoThera Inc Pulsar Vascular, Inc. Pulse Therapeutics Inc Rapid Medical Rontis AG Shape Memory Therapeutics, Inc. Sree Chitra Tirunal Institute for Medical Sciences & Technology Strategic Polymer Sciences, Inc Taewoong Medical Co Ltd Terumo Corp Triticum Medical Ltd. Twin Star Medical Inc University of California Los Angeles University of California San Francisco University of Minnesota University of South Florida University of Wisconsin Madison University of Wolverhampton Valor Medical Inc Vascular Solutions Inc Viket Medical Corporation Weill Cornell Medical College Zoll Medical Corporation

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###